Rapport Therapeutics, Inc. financial data

Symbol
RAPP on Nasdaq
Location
1325 Boylston Street, Suite 401, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity -48.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.6M shares
Common Stock, Shares, Outstanding 36.6M shares
Common Stock, Value, Issued 36K USD
Weighted Average Number of Shares Outstanding, Basic 34.9M shares +2179%
Weighted Average Number of Shares Outstanding, Diluted 34.9M shares +2179%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 15.5M USD +105%
General and Administrative Expense 6.1M USD +207%
Operating Income (Loss) -21.6M USD -126%
Nonoperating Income (Expense) 4.1M USD +379%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17.5M USD -101%
Net Income (Loss) Attributable to Parent -71.9M USD -101%
Earnings Per Share, Basic -0.5 USD/shares +91.2%
Earnings Per Share, Diluted -0.5 USD/shares +91.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 39.3M USD -75.3%
Cash, Cash Equivalents, and Short-term Investments 321M USD
Assets, Current 326M USD
Property, Plant and Equipment, Net 3.41M USD
Operating Lease, Right-of-Use Asset 1.61M USD
Other Assets, Noncurrent 189K USD
Assets 331M USD
Accounts Payable, Current 1.32M USD
Employee-related Liabilities, Current 3.23M USD
Accrued Liabilities, Current 5.06M USD
Liabilities, Current 7.1M USD
Operating Lease, Liability, Noncurrent 931K USD
Liabilities 8.03M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 400K USD
Retained Earnings (Accumulated Deficit) -104M USD
Stockholders' Equity Attributable to Parent 323M USD
Liabilities and Equity 331M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500M shares
Common Stock, Shares, Issued 36.6M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Depreciation 200K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17M USD -94.7%
Property, Plant and Equipment, Gross 4.11M USD
Operating Lease, Liability, Current 720K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.18M USD +270%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares